Research
Cartalax — living evidence map
The Atlas page holds the claims; this is how its evidence evolved.
Summary
In human mesenchymal stem cells during replicative ageing, the AED peptide activated gene expression and synthesis of the chondrogenic proteins SOX9, aggrecan, type II collagen and COMP. · pmid:37782646
Identity
PubChem CID 87815447: Alanyl-glutamyl-aspartic acid, C12H19N3O8, 333.29 g/mol. · pubchem:87815447
IUPAC name: (2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-carboxybutanoyl]amino]butanedioic acid. · pubchem:87815447
Where the evidence actually sits
Proportion of the 1 claim about Cartalax standing at each tier. Community volume is shown on the Consensus tab beside this and is never averaged into it.
Living evidence history
1 resolved citation, oldest to newest, coloured by tier. Retractions and contradictions land here as they are recorded.
Structure
No structure representation on record. PepJunkie draws only what an authoritative record supplies; for a peptide that is the residue sequence, and none has been curated for Cartalax yet.
Dose evidence, rung by rung
No established safe human dose. Nothing on file establishes one. That is a statement about the evidence PepJunkie holds, not a promise about the molecule.
- Approved-label dose · a resolved regulatory document names a labelled dose
nothing resolved on this rung
- Studied human doses · resolved human studies at the established tier
nothing resolved on this rung
- Observational evidence · resolved human data at the emerging tier: thin, or contested
nothing resolved on this rung
- Community-reported protocols · protocol propositions from distinct members, counted once per human
nothing resolved on this rung
- Preclinical evidence · resolved animal, cell or mechanistic work
- [The influence of peptides on the chondrogenic differentiation of human mesenchymal stem cells during replicative aging.]. · pmid 37782646 · 2023
1 resolved citation, 0 unresolved (an unresolved citation lends nothing). Community volume is its own rung and is never averaged into the evidence rungs.